• Medical_Professionals
• Medical_students
• Nurses

Attend the complimentary ticketed networking session to discuss with faculty your career development, mentorship, and optimizing the fellowship experience

USD

Group registrations not allowed

Accompanying persons not allowed

We don’t accept Online Abstracts

Moscone West Building

800 Howard Street

San Francisco, CA 94103

Submission Info

Please make special note of the following when preparing your abstract

Describe the objectives and results of the research in the abstract so that the Program Committee can evaluate the quality and completeness of the abstract. Abstracts will be judged solely on the basis of the data in the submitted abstract.

Organize the abstract according to four sections, identified by the following headers: Background, Methods, Results, and Conclusions.

Do not use proprietary names in the title or body of the abstract. If necessary, you may include the proprietary name in parentheses directly after the generic name on first use in the body of the abstract.

Do not refer to study results or conclusions in the title of the abstract. The title should objectively describe the study. The Program Committee reserves the right to edit conclusive titles.

You may include one data table with the abstract. Do not include illustrations or graphics.

Do not exceed 2,000 characters (approximately 300-350 words), not including spaces, for the total of your abstract title, body, and table.

Individuals may serve as first author of more than one abstract.

List no more than 20 individual authors for each abstract. Make sure that all coauthors meet the definition of authorship as stated by the International Committee of Medical Journal Editors in the “Uniform Requirements for Manuscripts Submitted to Biomedical Journals.” In addition to the 20 authors, an authoring group may also be listed to indicate the remaining authors.

Although clinical trial registration is not required for abstract submission, publication, or presentation, certain clinical trials are required to be registered by law and/or prior to journal publication. If a clinical trial is already registered, the first author will be asked to provide the name of the registry and the trial registration number during the abstract submission process. The clinical trial number will be included in the published abstract.

In order to successfully complete an online submission, authors will need to provide the following information:

First Author (Presenting Author): The name, institution, telephone number, and email address of the first author is required. The first author (presenting author) will receive all future correspondence from ASCO.

Coauthor(s): The name, institution, and email address of each coauthor. Academic degrees of coauthors are not needed.

Intent to Submit Late-Breaking Data Submission: This box must be checked (either yes or no). Abstracts lacking data in the Results section of the abstract will be considered for late-breaking status only when this box is checked.

Disease Site/Topic Category: Select the most appropriate disease site and topic category for the abstract, according to the list of topics online (which also appears above). Please note that the Program Committee has the authority to recategorize an abstract.

Disclosure Declaration: Disclosure of all relationships with companies for the first author and all coauthors is required.

The Symposium is a specialized meeting designed to highlight the latest science in GI cancers and information oncologists of all subspecialties need to know now, in order to provide the highest quality of care to patients.

The intimate exhibit area provides a level playing field for the select organizations that secure exhibit space. The exhibit area is comprised of table top exhibits and poster presentations. In addition, breakfast, lunch, and breaks are served in the same room, providing ample opportunity for interaction with attendees. 

Table Top Rate

Standard - $4,995

Certain Conquer Cancer Foundation supporters may receive a discount for exhibiting; please contact the Conquer Cancer Foundation for more details. The venue information is below.

Exhibits will be held on Level 1 during the following hours:

Thursday, January 21: 7:00 AM - 7:00 PM

Friday, January 22: 6:55 AM - 7:00 PM

Moscone West Building

800 Howard Street

San Francisco, CA 94103